Huimee Medical (03309) announced that the company's board of directors (the board of directors) received a notification from the company's chairman, CEO and executive director, Dr. Lin Shunchao, that he has purchased a total of 0.792 million shares of the company's stock (shares) in the market since July 15, 2024, at a total cost of HKD 2.077 million, equivalent to an average price of approximately HKD 2.62 per share (for purchases from July 15 to July 17), or about 0.063% of the company's issued share capital.
Prior to the purchase from July 15 to July 17, Dr. Lin, together with Huimee Group Limited (the company's controlling shareholder, owned 70% by Dr. Lin and 30% by his spouse and the company's executive director, Ms. Li Xiaoting), held approximately 54.88% of the company's issued share capital. Following the purchase from July 15 to July 17, Dr. Lin, together with Huimee Group Limited, currently holds approximately 54.95% of the company's issued share capital.
Comment(0)
Reason For Report